1/5

FIEO Registered Export Ready

Tranexamic Acid Injection BP (100mg/ml)

Name: Tranexamic Acid Injection BP (100mg/ml)
SKU: 8601381
Availability: InStoreOnly

Sold by ancalima lifesciences limited · Manufacturer, Exporter · Murthal, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

IN +3 others

Values shown are for ancalima lifesciences limited.

Compliance & Certifications

ISO 9001:2015

Suitable for

Importers · Distributors · Wholesalers

Murthal Dispatch on request FIEO member

ancalima lifesciences limited

Manufacturer, Exporter · Murthal, Haryana, India

Ancalima is manufacturer & exporter of Cosmetic & Pharmaceutical Formulations.

Registered address: Sonipat, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

View profile All products

Established

1970

Employees

11–30

GST

06AACCP5005B1Z4

IEC code

3395003396

Export markets

IN +3 others

GlobalLinker Member Since

May 2021

Turnover

2500001 - 10000000.

Incorporation Type

On request

ISO 9001:2015 ISO 9001:2015

Product details

What are the specifications of this product?

Overview

Tranexamic Acid Injection BPTranexamic Acid Injection BP is a biocompatible injectable formulation designed to inhibit fibrinolysis and stabilize clot formation. The 100mg/ml concentration ensures precise dosing for clinical hemostatic interventions.This standardized dosage supports rapid hemostatic control, making it suitable for surgical, trauma, and institutional applications.Key Features:High solubility and stability in isotonic solutionOptimized for rapid systemic fibrinolytic inhibitionMinimizes injection site irritation due to controlled pHSingle-use vial ensures dosage accuracyAttributes:100mg/ml per vial for predictable therapeutic effectInjectable formulation with uniform flowSuitable for bulk hospital and institutional procurement

Product Description

Composition and Formulation Details

The formulation contains pharmaceutically pure tranexamic acid dissolved in sterile isotonic medium with stabilizers to maintain chemical integrity and solubility. This ensures accurate dosing and long-term stability for clinical use.

Functional Characteristics and Performance

The low-viscosity injectable provides smooth systemic administration, rapid hemostatic action, and predictable pharmacokinetics. Shelf-stable under controlled conditions, it allows for repeatable therapeutic performance.

Application and Industry Relevance

Used widely in hospitals, surgical centers, and trauma care, this injection is suitable for bulk sourcing, OEM supply, and export-ready pharmaceutical operations. Its standardized 100mg/ml dosage ensures reliable performance in professional B2B markets requiring precise hemostatic intervention.

Description provided by ancalima lifesciences limited.

Specifications

Active Substance	Tranexamic Acid
Concentration	100mg per ml
Total Strength	500mg per ampoule (5ml)
Dosage Form	Injection Solution
Compliance	British Pharmacopoeia (BP)
Packaging Type	Ampoule
Pack Size	Tray pack of 5 ampoules
Intended Use	Treatment of bleeding disorders and surgical bleeding
Shelf Life	Refer to manufacturer's details
Storage Instructions	Store in a cool, dry place below 25°C, avoid light exposure

Use cases

Category	Pharmaceuticals > Injectable Solutions > Antifibrinolytic Agents
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Tranexamic Acid Injection BP (100mg/ml). Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the concentration and strength of the Tranexamic Acid Injection BP?

A: The injection has a concentration of 100mg/ml and a total strength of 500mg per 5ml ampoule.

Q: How is the Tranexamic Acid Injection BP packaged for supply?

A: It is supplied in a tray pack containing 5 ampoules, each ampoule having 5ml of solution.

Q: What pharmacopeia standard does this Tranexamic Acid Injection comply with?

A: This product is manufactured according to the British Pharmacopoeia (BP) standards.

Q: What therapeutic use is the Tranexamic Acid Injection intended for?

A: It is intended for use as an antifibrinolytic agent to prevent excessive bleeding during surgery or bleeding disorders.

Q: What are the storage requirements for this product?

A: The injection should be stored below 25°C, protected from light, in a cool and dry place.

Question not answered? Ask sellers directly — typical response within 4 hours.